Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2536 to 2550 of 9128 results

  1. Suspected sepsis in pregnancy: recognition, diagnosis and early management

    In development Reference number: GID-NG10468 Expected publication date:  17 March 2027

    NICE guideline
    In development

  2. Radiofrequency ablation of the basivertebral nerve for chronic low back pain

    Awaiting development Reference number: GID-HTG10871 Expected publication date: TBC

    HealthTech guidance
    Awaiting development

  3. Taletrectinib for treating ROS1-positive advanced non-small-cell lung cancer

    Awaiting development Reference number: GID-TA12467 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Cryoablation for Desmoid-type Fibromatosis

    Awaiting development Reference number: GID-HTG10872 Expected publication date: TBC

    HealthTech guidance
    Awaiting development

  5. Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

    In development Reference number: GID-HTG10870 Expected publication date:  15 October 2026

    HealthTech guidance
    In development

  6. Lutetium-177 vipivotide tetraxetan in combination for treating PSMA-positive hormone-sensitive metastatic prostate cancer [ID6589]

    In development Reference number: GID-TA11766 Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Transverse tibial transport for diabetic foot ulceration

    Awaiting development Reference number: GID-HTG10873 Expected publication date: TBC

    HealthTech guidance
    Awaiting development

  8. Heart valve disease presenting in adults: investigation and management - transcatheter aortic valve implantation (TAVI) to treat aortic stenosis (update)

    In development Reference number: GID-NG10457 Expected publication date: TBC

    NICE guideline
    In development

  9. Lenacapavir for preventing HIV-1 in people aged 16 years or older [ID6495]

    In development Reference number: GID-TA11638 Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (review of TA1068) [ID6682]

    Awaiting development Reference number: GID-TA11978 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Baxdrostat for treating uncontrolled or resistant hypertension [ID6623]

    In development Reference number: GID-TA11818 Expected publication date:  14 April 2027

    Technology appraisal guidance
    In development

  12. Norucholic acid for treating primary sclerosing cholangitis [ID6583]

    Awaiting development Reference number: GID-TA11782 Expected publication date:  29 April 2027

    Technology appraisal guidance
    Awaiting development

  13. Ex-situ machine perfusion devices to preserve deceased donor livers for transplantation

    In development Reference number: GID-HTG10874 Expected publication date:  20 August 2026

    HealthTech guidance
    In development

  14. Alectinib for treating unresectable locally advanced non-small-cell lung cancer [GID-TA12468]

    Awaiting development Reference number: GID-TA12468 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Technologies to improve detection of endometrial cancer

    Awaiting development Reference number: GID-HTG10173 Expected publication date: TBC

    HealthTech guidance
    Awaiting development